Age dependent assessment of TFPI levels in follicular fluid of women undergoing IVF

Clinica Chimica Acta

Volumn 361, Issue 1-2, 2005, Pages 176-181

  Thyzel, Elmar ^a   Siegling, Sabine ^a   Tinneberg, Hans Rudolf ^b   Götting, Christian ^a   Kleesiek, Knut ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b UNIVERSITY HOSPITAL GIESSEN   (Germany)

Author keywords

Human follicular fluid; In vitro fertilisation; Ovarian hyperstimulation syndrome; Tissue factor pathway inhibitor

Indexed keywords

TISSUE FACTOR PATHWAY INHIBITOR;

ADULT; AGE DISTRIBUTION; ARTICLE; CLINICAL ARTICLE; FEMALE; FERTILIZATION IN VITRO; HUMAN; OVARY DISEASE; OVARY FOLLICLE FLUID; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; THROMBOSIS;

ADULT; AGING; FEMALE; FERTILIZATION IN VITRO; FOLLICULAR FLUID; HUMANS; LIPOPROTEINS; OVARIAN HYPERSTIMULATION SYNDROME; PREGNANCY; PREGNANCY OUTCOME;

EID: 25644449637     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cccn.2005.05.022     Document Type: Article

References (32)

1. T. Brinkmann, M. Schmidt, W. Prohaska, and K. Kleesiek Tissue factor pathway inhibitor (TFPI): biochemistry, genetics and implications for thrombophilia J Lab Med 25 2001 269 276
2. M.S. Bajaj, J.J. Birktoft, S.A. Steer, and S.P. Bajaj Structure and biology of tissue factor pathway inhibitor (review) Thromb Haemost 86 2001 959 972
3. T.J. Girard, L.A. Warren, and W.F. Novotny Functional significance of the Kunitz-type inhibitory domains of lipoprotein-associated coagulation inhibitor Nature 338 1989 518 520
4. L.V. Rao Rapaport SI Studies of a mechanism inhibiting the initiation of the extrinsic pathway of coagulation Blood 69 1987 645 651
5. E. Thyzel, S. Siegling, C. Götting, H.R. Tinneberg, T. Brinkmann, and K. Kleesiek Quantification of tissue factor pathway inhibitor in human seminal plasma and in human follicular fluid Thromb Res 109 2003 329 332
6. B. Osterud, M.S. Bajaj, and S.P. Bajaj Sites of tissue factor pathway inhibitor (TFPI) and tissue factor expression under physiologic and pathologic conditions Thromb Haemost 73 1995 873 875
7. T. Brinkmann, H. Kaehnert, W. Prohaska, O. Nordfang, and K. Kleesiek Synthesis of tissue factor pathway inhibitor in human synovial cells and chondrocytes makes joints the predilected site of bleeding in haemophiliacs Eur J Clin Chem Clin Biochem 32 1994 313 317
8. A.M. Fulghesu, P. Villa, and V. Pavone The impact of insulin secretion on the ovarian response to exogenous gonadotropins in polycystic ovary syndrome J Clin Endocrinol Metab 82 1997 644 648
9. N.M. Caplice, C. Panetta, and T.E. Peterson Lipoprotein (a) binds and inactivates tissue factor pathway inhibitor: a novel link between lipoproteins and thrombosis Blood 98 2001 2980 2987
10. A.K. Lindahl, P.M. Sandset, and U. Abilgaard The present status of tissue factor pathway inhibitor Blood Coagul Fibrinolysis 3 1992 439 449
11. P. Lesnik, A. Vonica, M. Guerin, M. Moreau, and M.J. Chapman Anticoagulant activity of tissue factor pathway inhibitor in human plasma is preferentially associated with dense subspecies of LDL and HDL and with LP(a) Arterioscler Thromb 13 1993 1066 1075
12. J.B. Hansen, N.E. Huseby, P.M. Sandset, B. Svensson, V. Lyngmo, and A. Nordoy Tissue factor pathway inhibitor and lipoproteins. Evidence for association with and regulation by LDL in human plasma Arterioscler Thromb 14 1994 223 229
13. P.M. Sandset, U. Abilgaard, and M.L. Larsen Heparin induces release of extrinsic coagulation pathway inhibitor (EPI) Thromb Res 50 1988 803 813
14. M.A. Driancourt, A. Gougeon, D. Royère, and C. Thibault Ovarian function C. Thibault M.C. Levasseur R.H.F. Hunter Reproduction in mammals and man 1993 Ellipses Paris 281 305
15. S.G. Greenwald, and P.F. Terranova Follicular selection and its control E. Knobil J. Neill The physiology of reproduction 1988 Raven Press New York 387 445
16. P.A. Gentry, L. Plante, O.B. Schroeder, J. LaMarre, J.E. Young, and W.G. Dodds Human ovarian fluid has functional systems for the generation and modulation of thrombin Fertil Steril 73 2000 848 854
17. C. Götting, J. Kuhn, H.R. Tinneberg, T. Brinkmann, and K. Kleesiek High xylosyltransferase activities in human follicular fluid and cultured granulosa-lutein cells Mol Hum Reprod 8 2002 1079 1086
18. H. Shimada, S. Kasakura, M. Shiotani, K. Nakamura, M. Ikeuchi, and T. Hoshino Hypocoaguable state of human preovulatory ovarian follicular fluid: role of sulfated proteoglycan and tissue factor pathway inhibitor in the fluid Biol Reprod 64 2001 1739 1745
19. P.A. Bergh, and D. Navot Ovarian hyperstimulation syndrome: a review of pathophysiology J Assist Reprod Genet 9 1992 429 438
20. Y. Abramov, U. Elchalal, and J.G. Schenker Debate: an 'epidemic' of severe OHSS: a price we have to pay? Hum Reprod 14 1999 2181 2185
21. B. Rizk, M. Aboulghar, J. Smitz, and R. Ron-el The role of vascular endothelial growth factor and interleukins in the pathogenesis of severe ovarian hyperstimulation syndrome Hum Reprod Update 3 1997 255 266
22. K. Ishikawa, T. Ohba, N. Tanaka, M. Iqbal, Y. Okamura, and H. Okamura Organ-specific production control of vascular endothelial growth factor in ovarian hyperstimulation syndrome-model rats Endocr J 50 2003 515 525
23. E. Rabau, A. David, D.M. Serr, S. Mashiach, and B. Lunenfeld Human menopausal gonadotropins for anovulation and sterility. Results of 7 years of treatment Am J Obstet Gynecol 98 1967 92 98
24. J.G. Schenker, and D. Weinstein Ovarian hyperstimulation syndrome: a current survey Fertil Steril 30 1978 255 268
25. A. Golan, R. Ron-el, A. Herman, Y. Soffer, Z. Weinraub, and B. Caspi Ovarian hyperstimulation syndrome: an update review Obstet Gynecol Surv 44 1989 430 440
26. A. Lee, L.K. Christensen, R.L. Stouffer, K.A. Burry, and P.E. Patton Vascular endothelial growth factor levels in serum and follicular fluid of patients undergoing in vitro fertilization Fertil Steril 68 1997 305 311
27. A. Raziel, S. Friedler, M. Schachter, D. Strassburger, A. Mordechai, and R. Ron-El Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome Hum Reprod 17 2002 107 110
28. A. Rogolino, M.E. Coccia, and S. Fedi Hypercoagulability, high tissue factor and low tissue factor pathway inhibitor levels in severe ovarian hyperstimulation syndrome: possible association with clinical outcome Blood Coagul Fibrinolysis 14 2003 277 282
29. A. Enskog, M. Henriksson, M. Unander, L. Nilsson, and M. Brannstrom Prospective study of the clinical and laboratory parameters of patients in whom ovarian hyperstimulation syndrome developed during controlled ovarian hyperstimulation for in vitro fertilization Fertil Steril 71 1999 808 814
30. A. Delvigne, A. Demoulin, and J. Smitz The ovarian hyperstimulation syndrome in in-vitro fertilization: a Belgian multicentric study Clinical and biological features. Hum Reprod 8 1993 1353 1360
31. B. Rizk, and J. Smitz Ovarian hyperstimulation syndrome after superovulation using GnRh agonists for IVF and related procedures Hum Reprod 7 1992 320 327
32. T.A. Warr, B.J. Warn-Cramer, L.V. Rao, and S.I. Rapaport Human plasma extrinsic pathway inhibitor activity: I. Standardization of assay Blood 74 1989 201 206